{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/6352"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/6352","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Role of the Src Family Tyrosine Kinases in Mammary Tumorigenesis","abstract":"<p>Although previous studies have shown that a large proportion of human breast cancers possess elevated c-Src kinase activity its role in mammary tumorigenesis is not well defined. Polyoma virus middle T antigen is known to activate members of Src family kinases (c-Src and eYes). Indeed, mammary gland specific expression of middle T antigen in transgenic mice is known to result in induction of mammary tumors. To test the role played by c-Src and c-Yes activation in mammary tumorigenesis we interbred transgenic mice expressing the middle T antigen with mice lacking either functional c-Src or c-Yes. Mice expressing middle T antigen in the absence of functional c-Src failed to develop mammary tumors while absence of c-Yes did not have any effect. This observation suggests that activation of c-Src kinase plays an important role in mammary tumorigenesis while c-Yes is dispensable for this process.</p> <p>Activation of the RTK Neu is known to play an important role in breast cancer. Since c-Src tyrosine kinases appear to play a pivotal role in mammary tumorigenesis, 1 investigated whether the Src family members are involved in Neu mediated signaling and tumorigenesis. In vitro kinase assays revealed that c-Src and c-Yes kinase activities were elevated in Neu induced mammary tumors while Fyn kinase activity was not. The increase in kinase activity correlated with the ability of c-Src and c-Yes to associate with tyrosine phosphorylated Neu in vivo. This in vivo interaction is likely due to the ability of c-Src and c-Yes SH2 domains to directly associate with phosphorylated tyrosine(s) on Neu. Although other members of erbB family also play a role in breast cancer, my results suggest that among the RTKs that are known to activate c-Src (EGFR and Neu), c-Src and c-Yes interact only with Neu and not EGFR. These observations suggest that Src family kinases are involved in Neu mediated signaling and tumorigenesis and also suggest that Neu plays a role in EGF mediated activation of c-Src.</p> <p>Although both c-Src and c-Yes are activated by Neu and middle T antigen, only c-Src is required for middle T mediated tumorigenesis. Indeed c-Src associates with a novel protein, p89, in transformed epithelial cells while c-Yes does not. Future identification of p89 will enable us to understand the mechanism by which c-Src transforms mammary epithelium.</p>","abstract_html":"&lt;p&gt;Although previous studies have shown that a large proportion of human breast cancers possess elevated c-Src kinase activity its role in mammary tumorigenesis is not well defined. Polyoma virus middle T antigen is known to activate members of Src family kinases (c-Src and eYes). Indeed, mammary gland specific expression of middle T antigen in transgenic mice is known to result in induction of mammary tumors. To test the role played by c-Src and c-Yes activation in mammary tumorigenesis we interbred transgenic mice expressing the middle T antigen with mice lacking either functional c-Src or c-Yes. Mice expressing middle T antigen in the absence of functional c-Src failed to develop mammary tumors while absence of c-Yes did not have any effect. This observation suggests that activation of c-Src kinase plays an important role in mammary tumorigenesis while c-Yes is dispensable for this process.&lt;/p&gt; &lt;p&gt;Activation of the RTK Neu is known to play an important role in breast cancer. Since c-Src tyrosine kinases appear to play a pivotal role in mammary tumorigenesis, 1 investigated whether the Src family members are involved in Neu mediated signaling and tumorigenesis. In vitro kinase assays revealed that c-Src and c-Yes kinase activities were elevated in Neu induced mammary tumors while Fyn kinase activity was not. The increase in kinase activity correlated with the ability of c-Src and c-Yes to associate with tyrosine phosphorylated Neu in vivo. This in vivo interaction is likely due to the ability of c-Src and c-Yes SH2 domains to directly associate with phosphorylated tyrosine(s) on Neu. Although other members of erbB family also play a role in breast cancer, my results suggest that among the RTKs that are known to activate c-Src (EGFR and Neu), c-Src and c-Yes interact only with Neu and not EGFR. These observations suggest that Src family kinases are involved in Neu mediated signaling and tumorigenesis and also suggest that Neu plays a role in EGF mediated activation of c-Src.&lt;/p&gt; &lt;p&gt;Although both c-Src and c-Yes are activated by Neu and middle T antigen, only c-Src is required for middle T mediated tumorigenesis. Indeed c-Src associates with a novel protein, p89, in transformed epithelial cells while c-Yes does not. Future identification of p89 will enable us to understand the mechanism by which c-Src transforms mammary epithelium.&lt;/p&gt;","abstract_has_math":false,"creators":["Muthuswamy, Senthil K."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Biology","school":null,"contributors":[],"advisors":["Muller, William J."],"committee_chairs":[],"committee_members":[],"year":1995,"date_issued":"1995-07","date_published":"1995-07","updated_at":"2026-11-18T19:38:38Z","subjects":["Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/21610"],"render_values":[{"text":"https://doi.org/10.71548/21610","href":"https://doi.org/10.71548/21610","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/1668","3233","1368180"],"render_values":[{"text":"opendissertations/1668","href":null,"code":true},{"text":"3233","href":null,"code":true},{"text":"1368180","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/6352","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/6352","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F6352","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Muller, William J."]},{"key":"dc:contributor.department","label":"Department","values":["Biology"]},{"key":"dc:creator","label":"Author","values":["Muthuswamy, Senthil K."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:35:09Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:35:09Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2010-06-22"]},{"key":"dc:date.issued","label":"Date","values":["1995-07"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/1668","3233","1368180"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/6352","https://doi.org/10.71548/21610"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Although previous studies have shown that a large proportion of human breast cancers possess elevated c-Src kinase activity its role in mammary tumorigenesis is not well defined. Polyoma virus middle T antigen is known to activate members of Src family kinases (c-Src and eYes). Indeed, mammary gland specific expression of middle T antigen in transgenic mice is known to result in induction of mammary tumors. To test the role played by c-Src and c-Yes activation in mammary tumorigenesis we interbred transgenic mice expressing the middle T antigen with mice lacking either functional c-Src or c-Yes. Mice expressing middle T antigen in the absence of functional c-Src failed to develop mammary tumors while absence of c-Yes did not have any effect. This observation suggests that activation of c-Src kinase plays an important role in mammary tumorigenesis while c-Yes is dispensable for this process.</p> <p>Activation of the RTK Neu is known to play an important role in breast cancer. Since c-Src tyrosine kinases appear to play a pivotal role in mammary tumorigenesis, 1 investigated whether the Src family members are involved in Neu mediated signaling and tumorigenesis. In vitro kinase assays revealed that c-Src and c-Yes kinase activities were elevated in Neu induced mammary tumors while Fyn kinase activity was not. The increase in kinase activity correlated with the ability of c-Src and c-Yes to associate with tyrosine phosphorylated Neu in vivo. This in vivo interaction is likely due to the ability of c-Src and c-Yes SH2 domains to directly associate with phosphorylated tyrosine(s) on Neu. Although other members of erbB family also play a role in breast cancer, my results suggest that among the RTKs that are known to activate c-Src (EGFR and Neu), c-Src and c-Yes interact only with Neu and not EGFR. These observations suggest that Src family kinases are involved in Neu mediated signaling and tumorigenesis and also suggest that Neu plays a role in EGF mediated activation of c-Src.</p> <p>Although both c-Src and c-Yes are activated by Neu and middle T antigen, only c-Src is required for middle T mediated tumorigenesis. Indeed c-Src associates with a novel protein, p89, in transformed epithelial cells while c-Yes does not. Future identification of p89 will enable us to understand the mechanism by which c-Src transforms mammary epithelium.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["Role of the Src Family Tyrosine Kinases in Mammary Tumorigenesis"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Muller, William J."],"dc:contributor.department":["Biology"],"dc:creator":["Muthuswamy, Senthil K."],"dc:date.accessioned":["2014-06-18T16:35:09Z"],"dc:date.available":["2014-06-18T16:35:09Z"],"dc:date.created":["2010-06-22"],"dc:date.issued":["1995-07"],"dc:description.abstract":["<p>Although previous studies have shown that a large proportion of human breast cancers possess elevated c-Src kinase activity its role in mammary tumorigenesis is not well defined. Polyoma virus middle T antigen is known to activate members of Src family kinases (c-Src and eYes). Indeed, mammary gland specific expression of middle T antigen in transgenic mice is known to result in induction of mammary tumors. To test the role played by c-Src and c-Yes activation in mammary tumorigenesis we interbred transgenic mice expressing the middle T antigen with mice lacking either functional c-Src or c-Yes. Mice expressing middle T antigen in the absence of functional c-Src failed to develop mammary tumors while absence of c-Yes did not have any effect. This observation suggests that activation of c-Src kinase plays an important role in mammary tumorigenesis while c-Yes is dispensable for this process.</p> <p>Activation of the RTK Neu is known to play an important role in breast cancer. Since c-Src tyrosine kinases appear to play a pivotal role in mammary tumorigenesis, 1 investigated whether the Src family members are involved in Neu mediated signaling and tumorigenesis. In vitro kinase assays revealed that c-Src and c-Yes kinase activities were elevated in Neu induced mammary tumors while Fyn kinase activity was not. The increase in kinase activity correlated with the ability of c-Src and c-Yes to associate with tyrosine phosphorylated Neu in vivo. This in vivo interaction is likely due to the ability of c-Src and c-Yes SH2 domains to directly associate with phosphorylated tyrosine(s) on Neu. Although other members of erbB family also play a role in breast cancer, my results suggest that among the RTKs that are known to activate c-Src (EGFR and Neu), c-Src and c-Yes interact only with Neu and not EGFR. These observations suggest that Src family kinases are involved in Neu mediated signaling and tumorigenesis and also suggest that Neu plays a role in EGF mediated activation of c-Src.</p> <p>Although both c-Src and c-Yes are activated by Neu and middle T antigen, only c-Src is required for middle T mediated tumorigenesis. Indeed c-Src associates with a novel protein, p89, in transformed epithelial cells while c-Yes does not. Future identification of p89 will enable us to understand the mechanism by which c-Src transforms mammary epithelium.</p>"],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.other":["opendissertations/1668","3233","1368180"],"dc:identifier.uri":["http://hdl.handle.net/11375/6352","https://doi.org/10.71548/21610"],"dc:subject":["Biology"],"dc:title":["Role of the Src Family Tyrosine Kinases in Mammary Tumorigenesis"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:38:38Z"}